Plantor OÜ

Active Registry code 16547226 OÜ Tallinn Registered 3 Aug 2022
Compare

Plantor OÜ is a OÜ based in Tallinn, registry code 16547226, status: active. Main activity: Manufacture of basic pharmaceutical products. According to EMTA, turnover for Q3 2026 was €0 with employees.

Turnover
0 €
↓ 100.0% vs Q2 2026
State taxes
—
Labour taxes
—
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Manufacture of basic pharmaceutical products and pharmaceutical preparations · EMTAK 21

  • Revenue · 2025 19 563 €
    industry median 48 003 € · companies in the industry: 19
  • Net profit margin · 2025 87.3 %
    industry median 9.8 % · companies in the industry: 15

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · −100.0% vs Q2 2026 · industry median 234 187 € · above 2% of the industry
0100 000200 000300 000400 000500 000Q4 2023 Company: 3 600 € Industry median: 102 827 €Q4·23Q1 2024 Company: 14 550 € Industry median: 160 070 €Q2 2024 Company: 0 € Industry median: 216 097 €Q2·24Q3 2024 Company: 118 € Industry median: 261 493 €Q4 2024 Company: 10 562 € Industry median: 198 576 €Q4·24Q1 2025 Company: 2 530 € Industry median: 231 372 €Q2 2025 Company: 835 € Industry median: 292 853 €Q2·25Q3 2025 Company: 0 € Industry median: 423 731 €Q4 2025 Company: 0 € Industry median: 410 601 €Q4·25Q1 2026 Company: 694 € Industry median: 375 496 €Q2 2026 Company: 1 100 € Industry median: 198 786 €Q2·26Q3 2026 Company: 0 € Industry median: 234 187 €Q3·260100 000200 000300 000400 000500 000Q4 2024 Company: 10 562 € Industry median: 198 576 €Q1 2025 Company: 2 530 € Industry median: 231 372 €Q1·25Q2 2025 Company: 835 € Industry median: 292 853 €Q3 2025 Company: 0 € Industry median: 423 731 €Q3·25Q4 2025 Company: 0 € Industry median: 410 601 €Q1 2026 Company: 694 € Industry median: 375 496 €Q1·26Q2 2026 Company: 1 100 € Industry median: 198 786 €Q3 2026 Company: 0 € Industry median: 234 187 €Q3·26
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

State taxes, € Q4 2025: 0 €
0.00.00.00.00.00.0Q4 2023 Company: —Q4·23Q1 2024 Company: —Q2 2024 Company: —Q2·24Q3 2024 Company: —Q4 2024 Company: —Q4·24Q1 2025 Company: 0 €Q2 2025 Company: —Q2·25Q3 2025 Company: —Q4 2025 Company: 0 €Q4·25Q1 2026 Company: —Q2 2026 Company: —Q2·26Q3 2026 Company: —Q3·260.00.00.00.00.00.0Q4 2024 Company: —Q1 2025 Company: 0 €Q1·25Q2 2025 Company: —Q3 2025 Company: —Q3·25Q4 2025 Company: 0 €Q1 2026 Company: —Q1·26Q2 2026 Company: —Q3 2026 Company: —Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — — — —
Q2 2026 1 100 — — —
Q1 2026 694 — — —
Q4 2025 — — — —
Q3 2025 — — — —
Q2 2025 835 — — —
Q1 2025 2 530 — — —
Q4 2024 10 562 — — —
Q3 2024 118 — — —
Q2 2024 — — — —
Q1 2024 14 550 — — —
Q4 2023 3 600 — — —
Q3 2023 1 800 — — —
Q2 2023 2 599 — — —
Q1 2023 — — — —
Q4 2022 — — — —
Q3 2022 — — — —

Financials by year

2023 – 2025
Revenue, € 2025: 19 563 € · +648.4% vs 2024 · industry median 48 003 € · above 40% of the industry
010 00020 00030 00040 00050 0002023 Company: 21 954 € Industry median: 3 851 €20232024 Company: 2 614 € Industry median: 25 284 €20242025 Company: 19 563 € Industry median: 48 003 €2025010 00020 00030 00040 00050 0002023 Company: 21 954 € Industry median: 3 851 €20232024 Company: 2 614 € Industry median: 25 284 €2025 Company: 19 563 € Industry median: 48 003 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 17 084 € · +256.1% vs 2024 · industry median 676 € · above 70% of the industry
-20 000-10 000010 00020 0002023 Company: 9 954 € Industry median: 0 €20232024 Company: -10 946 € Industry median: 0 €20242025 Company: 17 084 € Industry median: 676 €2025-20 000-10 000010 00020 0002023 Company: 9 954 € Industry median: 0 €20232024 Company: -10 946 € Industry median: 0 €2025 Company: 17 084 € Industry median: 676 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 87.3 % · +506.1 pp vs the year before · industry median 9.8 % · above 98% of the industry
-600-400-20002002023 Company: 45.3 % Industry median: 4.4 %20232024 Company: -418.7 % Industry median: 1.2 %20242025 Company: 87.3 % Industry median: 9.8 %2025-600-400-20002002023 Company: 45.3 % Industry median: 4.4 %20232024 Company: -418.7 % Industry median: 1.2 %2025 Company: 87.3 % Industry median: 9.8 %2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 22 966 € · +316.4% vs 2024
05 00010 00015 00020 00025 0002023 Company: 18 997 €20232024 Company: 5 516 €20242025 Company: 22 966 €202505 00010 00015 00020 00025 0002023 Company: 18 997 €20232024 Company: 5 516 €2025 Company: 22 966 €2025
Equity, € 2025: 18 593 € · +1 133.0% vs 2024
05 00010 00015 00020 0002023 Company: 12 454 €20232024 Company: 1 508 €20242025 Company: 18 593 €202505 00010 00015 00020 0002023 Company: 12 454 €20232024 Company: 1 508 €2025 Company: 18 593 €2025
Employees 2025: 0 · industry median 28 · above 2% of the industry
0102030402023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 3220242025 Company: 0 Industry median: 2820250102030402023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 322025 Company: 0 Industry median: 282025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 19 563 17 084 0 22 966 18 593 0
2024 2 614 -10 946 0 5 516 1 508 0
2023 21 954 9 954 0 18 997 12 454 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
87.3 %
Net profit / revenue
Return on equity (ROE)
91.9 %
Net profit / equity
Return on assets (ROA)
74.4 %
Net profit / assets
Equity ratio
81.0 %
Equity / assets
Debt ratio
19.0 %
Liabilities / assets
Current ratio
4.56
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 15 Sep 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 30 Jun 2025 Company’s own e-Äriregister
2023 3 Aug 2022 – 31 Dec 2023 7 Oct 2024 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 21101Manufacture of basic pharmaceutical products Main
Rulings
Number, date Title Deadline State Document
Ä 50207937 / M2
7 Sep 2024
Warning of deletion from the register: annual report not filed 11 Dec 2024 Deficiencies eliminated
8 Oct 2024
PDF
Ä 50207937 / M1
19 Jul 2024
Warning of deletion from the register: annual report not filed 22 Oct 2024 Deficiencies eliminated
24 Aug 2024
PDF
Ä 50207937 / 3
22 Dec 2023
Amendment entry In force
22 Dec 2023
PDF
Ä 50207937 / 2
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 50207937
3 Aug 2022
First entry In force
3 Aug 2022
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data